
Sign up to save your podcasts
Or


Dr. Karine Tawagi joins the show to detail prostate cancer data from ESMO 2025 that carries the most important clinical implications. What trial data mattered the most? Take a listen and join the conversation.
By Chadi NabhanDr. Karine Tawagi joins the show to detail prostate cancer data from ESMO 2025 that carries the most important clinical implications. What trial data mattered the most? Take a listen and join the conversation.